Thursday, June 30, 2011 2:02:11 PM
http://finance.yahoo.com/news/Sangamo-BioSciences-Announces-prnews-2575673128.html?x=0&.v=1
"RICHMOND, Calif., June 27, 2011 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq:SGMO - News) announced today the publication of a groundbreaking preclinical study demonstrating permanent functional correction of the gene that causes hemophilia B by the systemic delivery of zinc finger nucleases (ZFNs) . The study, published in Nature, represents a significant advance in the development and systemic delivery of ZFP Therapeutics® and proof of concept for ZFN-based gene-editing for the treatment of hemophilia and other monogenic diseases. "
This is very dramatic evidence that zinc fingers work. I would expect it to have some effect on KBLB's SP as well although lagging and much less pronounced - some will realize the connection between SGMO's zinc fingers and KBLB's zinc fingers and decide to put some money on KBLB as well,IMHO. Hopefully enough to put a floor on the SP and some upward movement.
We already know that zinc fingers have been proven to work in the silkwom:
Targeted mutagenesis in the silkworm Bombyx mori using zinc finger nuclease mRNA injection
http://www.ncbi.nlm.nih.gov/pubmed/20692340
The hemophilia cure in mice shows that genes altered by zinc fingers do what they are supposed to do (in at least some cases).
The odds for success for pure spider silk look even better with that news.
A VERY important distinction to notice in that news: the mice had only a few percent increase in clotting factor (but it was enough). That was because that use of zinc fingers was to make genetic modications in *some* of the cells in an adult animal. In contrast the KBLB ZF modifications will be to eggs and will result in the gene being added to ALL cells in the silkworms (because it will be done in the single cell stage. So the protein will be produced by all cells (of the relevant type) rather than just a small percentage as with the hemophilic mice. So anyone who says that, "yeah but it was only a few percent in the mice, so the worms may not produce enough spider silk protein", is either confused or is tying to mislead you. GMs at the single cell stage make changes that are then present in every single cell of the organism (and in all of its descendents.
Pure spider silk from silkworms = penny stock no more.
Recent KBLB News
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 06/10/2024 08:30:30 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 06/04/2024 04:15:03 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/22/2023 09:31:54 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/16/2023 09:30:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:43:51 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/11/2023 08:30:50 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 09/01/2023 08:30:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:35:05 PM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM